Eriani G, Cavarelli J, Martin F, Dirheimer G, Moras D, Gangloff J
Structure des Macromolécules Biologiques et Mécanismes de Reconnaissance UPR 9002, Strasbourg, France.
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10816-20. doi: 10.1073/pnas.90.22.10816.
Cytoplasmic aspartyl-tRNA synthetase (AspRS; EC 6.1.1.12) from yeast is, as are most class II synthetases, an alpha 2 dimer. The only invariant amino acid in signature motif 1 of this class is Pro-273; this residue is located at the dimer interface. To understand the role of Pro-273 in the conserved dimeric configuration, we tested the effect of a Pro-273-->Gly (P273G) substitution on the catalytic properties of homo- and heterodimeric AspRS. Heterodimers of AspRS were produced in vivo by overexpression of their respective subunit variants from plasmid-encoded genes and purified to homogeneity in one HPLC step. The homodimer containing the P273G shows an 80% inactivation of the enzyme and an affinity decrease for its cognate tRNA(Asp) of one order of magnitude. The P273G-mutated subunit recovered wild-type enzymatic properties when associated with a native subunit or a monomer otherwise inactivated having an intact dimeric interface domain. These results, which can be explained by the crystal structure of the native enzyme complexed with its substrates, confirm the structural importance of Pro-273 for dimerization and clearly establish the functional interdependence of the AspRS subunits. More generally, the dimeric conformation may be a structural prerequisite for the activity of mononucleotide binding sites constructed from antiparallel beta strands.
来自酵母的细胞质天冬氨酰 - tRNA合成酶(AspRS;EC 6.1.1.12)与大多数II类合成酶一样,是一种α2二聚体。该类酶特征基序1中唯一不变的氨基酸是Pro - 273;该残基位于二聚体界面。为了解Pro - 273在保守二聚体结构中的作用,我们测试了Pro - 273→Gly(P273G)取代对同型和异型二聚体AspRS催化特性的影响。通过从质粒编码基因过表达各自的亚基变体,在体内产生AspRS的异型二聚体,并通过一步高效液相色谱法纯化至同质。含有P273G的同型二聚体显示该酶失活80%,并且其对同源tRNA(Asp)的亲和力降低一个数量级。当与天然亚基或具有完整二聚体界面结构域的否则失活的单体结合时,P273G突变的亚基恢复野生型酶活性。这些结果可由与底物复合的天然酶的晶体结构来解释,证实了Pro - 273对二聚化的结构重要性,并清楚地确立了AspRS亚基的功能相互依赖性。更一般地说,二聚体构象可能是由反平行β链构建的单核苷酸结合位点活性的结构先决条件。